首页> 外文期刊>Hepatitis Monthly >Hepatitis B Virus Genotype B and High Expression of Interferon Alpha Receptor ? Subunit are Associated With Better Response to Pegylated Interferon Alpha 2a in Chinese Patients With Chronic Hepatitis B Infection
【24h】

Hepatitis B Virus Genotype B and High Expression of Interferon Alpha Receptor ? Subunit are Associated With Better Response to Pegylated Interferon Alpha 2a in Chinese Patients With Chronic Hepatitis B Infection

机译:乙型肝炎病毒B型基因和干扰素α受体高表达?亚型与中国慢性乙型肝炎患者对聚乙二醇化干扰素α2a的更好反应相关

获取原文
       

摘要

Background: Hepatitis B virus (HBV) is one of leading causes of various hepatic diseases including acute and chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Hundreds of million people worldwide are infected by HBV, chronically. Objectives: This study in conducted to investigate the in?uence of Hepatitis B virus (HBV) genotypes and type I IFN-αreceptor β subunit (IFNAR2) expression in liver on response to treatment with pegylated IFN-α-2a (Peg-IFN-α-2a) for chronic hepatitis B infection. Patients and Methods: In this study, 65 eligible patients with chronic hepatitis B disease were enrolled. HBV genotypes of these patients were analyzed by using PCR-RFLP of the surface gene of HBV. The expression of IFNAR2 in the liver was immune histochemically investigated using anti-IFNAR2 antibody. All immune histochemical slides were read semi-quantitatively by image analysis. Chronic hepatitis B patients were treated with Peg-IFN-α2a therapy for a 48-week period and followed up for 24 weeks. Baseline characteristics and sustained viral response (SVR) to Peg-IFN-α-2a therapy were evaluated. Results: 55 % of patients exhibited HBV genotype B and 31.7 % patients exhibited HBV genotypes C infections. After treatment with Peg-IFN-α-2a, SVR was achieved in 66.7 % of patients with HBV genotype B and in 26.3 % of patients with HBV genotype C (P = 0.009). Semiquantitative and the image analysis indicated by gray level values revealed a higher IFNAR2 expression in the group with severe in?ammation (P < 0.001). Patients’ high IFNAR2 protein expression had a signi?cant impact on SVR to Peg-IFN-α-2a therapy (P = 0.028). Conclusions: HBV genotype B and high expression of IFNAR2 in the liver of chronic hepatitis B patients are closely associated with better response to Peg-IFN-α-2a therapy in chronic hepatitis B disease. Implication for health policy/practice/research/medical education: Hepatitis B Virus genotype B and high expression of interferon alpha receptor β subunit may be considered as a predictor of response to interferon antiviral therapy in HBV patients and study of this article is recommended to the hepatologists, virologists, gastroentestinalist and other researchers. Please cite this paper as: Fan HB, Guo YB, Zhu YF, Chen AS, Zhou MX, Li Z, et al. Hepatitis B Virus Genotype B and High Expression of Interferon Alpha Receptor β Subunit are Associated With Better Response to Pegylated Interferon Alpha 2a in Chinese Patients With Chronic Hepatitis B Infection. Hepat Mon. 2012;12(5): 333-8. DOI: 10.5812/hepatmon.6173 Copyright ? 2012 Kowsar Corp. All rights reserved.
机译:背景:乙型肝炎病毒(HBV)是各种肝病的主要原因之一,包括急慢性肝炎,肝硬化和肝细胞癌。全世界数以亿计的人长期感染HBV。目的:本研究旨在研究乙肝病毒基因型和PEG化IFN-α-2a(Peg-IFN-α)对肝脏中I型IFN-α受体β亚基(IFNAR2)表达的影响α-2a)用于慢性乙型肝炎感染。患者和方法:本研究招募了65位符合条件的慢性乙型肝炎患者。通过使用HBV表面基因的PCR-RFLP分析这些患者的HBV基因型。使用抗IFNAR2抗体对肝脏中IFNAR2的表达进行了免疫组织化学研究。通过图像分析半定量读取所有免疫组织化学玻片。慢性乙型肝炎患者接受了Peg-IFN-α2a治疗48周,随后进行了24周的随访。评估了基线特征和对Peg-IFN-α-2a治疗的持续病毒应答(SVR)。结果:55%的患者表现出HBV基因型B,31.7%的患者表现出HBV基因型C。用Peg-IFN-α-2a治疗后,在66.7%的HBV基因型B患者和26.3%的HBV基因型C患者中实现了SVR(P = 0.009)。半定量分析和灰度值显示的图像分析显示,严重炎症组中IFNAR2表达较高(P <0.001)。患者的IFNAR2高蛋白表达对SVR的Peg-IFN-α-2a治疗有重要影响(P = 0.028)。结论:慢性乙型肝炎患者肝脏中的HBV B基因型和IFNAR2高表达与慢性乙型肝炎患者对Peg-IFN-α-2a治疗的较好反应密切相关。对健康政策/实践/研究/医学教育的意义:乙型肝炎病毒基因型B和干扰素α受体β亚基的高表达可能被认为是HBV患者对干扰素抗病毒治疗反应的预测因子,建议对本文进行研究。肝病学家,病毒学家,胃肠病学家和其他研究者。请将此论文引用为:范HBB,郭延宝,朱育峰,陈AS,周MX,李Z等。乙型肝炎病毒基因型B和干扰素α受体β亚基的高表达与中国慢性乙型肝炎感染患者对聚乙二醇化干扰素α2a的更好反应有关。肝星期一2012; 12(5):333-8。 DOI:10.5812 / hepatmon.6173版权所有? 2012 Kowsar Corp.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号